| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/03/2004 | EP1392112A2 Sca2 knockout animal and methods of use |
| 03/03/2004 | EP1392111A1 Method for targeting transcriptionally active loci |
| 03/03/2004 | EP1149167B1 Viral vaccine |
| 03/03/2004 | EP1104993A4 C3a serum-free clonal cell line and methods of use |
| 03/03/2004 | EP1047437A4 Sea cucumber carotenoid lipid fraction products and methods of use |
| 03/03/2004 | EP1023467B1 Method for measuring viral infectivity |
| 03/03/2004 | EP1015017B1 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 03/03/2004 | EP0964875B1 5-hydroxytryptophol (5-htol) derivatives, antibodies, immunoassays and detection of recent alcohol consumption |
| 03/03/2004 | EP0948518B1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 03/03/2004 | EP0733103B1 Generation of high titers of recombinant aav vectors |
| 03/03/2004 | EP0633929B1 METHOD FOR $i(IN VITRO) PROLIFERATION OF DENDRITIC CELL PRECURSORS AND THEIR USE TO PRODUCE IMMUNOGENS |
| 03/03/2004 | CN1479786A Preparation of spheroids |
| 03/03/2004 | CN1479748A Anti-abnormal prion monoclonal antibody, process for producing the same and immunoassay method with the use thereof |
| 03/03/2004 | CN1479632A Complexes for transferring necleic acids into cells |
| 03/03/2004 | CN1478897A Plant polygene expression carrier, transforming factor containing said carrier and its application |
| 03/03/2004 | CN1478893A Paddy rice anti-reverse transcripfactor and its coding gene and application |
| 03/03/2004 | CN1478888A Method of embryo dry cell directed induction and differentiation as liver cell |
| 03/03/2004 | CN1140801C Method for detection of specific antigen reaction of lymphocyte in blood |
| 03/03/2004 | CN1140629C Genes of purine biosynthesis from ashbya gossypli and use thereof in microbial riboflavin synothesis |
| 03/02/2004 | US6700039 Use of target and organ specific promoters controlling expression of dna sequences inhibiting sprouting in plant vegetative storage organs (e.g., potato tubers) resulting in increased long term storage and minimal loss in food quality |
| 03/02/2004 | US6700038 Insect viral vectors useful in the transfer of genes to plants, insects and other hosts |
| 03/02/2004 | US6700037 Genetically engineering swine embryos; culture swine embryos, translocate nucleus to another swine embryo, activate oocyte, monitor embryo development |
| 03/02/2004 | US6699984 Genetic engineering in plants; dna sequences and constructs useful in controlling expression of recombinant genes in plants, constructs use novel regulatory sequences derived from maize root preferential cationic peroxidase gene |
| 03/02/2004 | US6699981 Generating prevential nucleotide sequences; obtain nucleotide sequences, incubate with primers, expose to polymerase, recover nucleotide sequences |
| 03/02/2004 | US6699972 Chimeric protein and method of controlling tumor growth using the protein |
| 03/02/2004 | US6699967 Used to treat, prevent, or delay a tissue proliferation-associated disorder |
| 03/02/2004 | US6699965 Used for as a drug screening target; protein from rat and human brains |
| 03/02/2004 | US6699721 Surface coatings for hot-melt adhesive film |
| 03/02/2004 | US6699716 In vivo induction for enhanced function of isolated hepatocytes |
| 03/02/2004 | US6699694 Method for producing α-1,6-branched α-1,4-glucans from sucrose |
| 03/02/2004 | US6699690 Linked and controlling the expression of a heterologous enzyme, for example varicella zoster virus thymidine kinase or non-mammaliam cytosine deaminase |
| 03/02/2004 | US6699686 Modified nuclear glucocorticoid receptor, fusion protein, and DNA fragments coding for said receptor and said fusion protein |
| 03/02/2004 | US6699672 Heparanase specific molecular probes and their use research and medical applications |
| 03/02/2004 | US6699671 Polypeptide sequence encoding beta secretase enzyme, termed aspartyl protease 2 (as p2) involved in processing amyloid precursor protein (app) into amyloid beta; drug screening for the enzyme inhibitor |
| 03/02/2004 | US6699669 Multistage electromagnetic separator for purifying cells, chemicals and protein structures |
| 03/02/2004 | US6699660 Isolated nucleic acid identical to one expressed in response to seizure or ischemia |
| 03/02/2004 | US6699657 In vitro system for replication of RNA-dependent RNA polymerase (RDRP) viruses |
| 03/02/2004 | US6699515 Process for the production of alcoholic beverages using maltseed |
| 03/02/2004 | US6699511 Isolation of inositol from carob extracts; obtain carob, expose to chhromatographic column, recover inositol |
| 03/02/2004 | US6699483 Cancer treatments |
| 03/02/2004 | US6699471 Biocompatible composition in the form of a gel for use in the treatment of, inflammation,tumors and bone disorders |
| 03/02/2004 | US6699470 Cartilage tissue replacement and repair |
| 03/02/2004 | US6699465 Chemical structure for use in the prevention and treatment of viral infections |
| 03/02/2004 | US6699287 Dermal scaffold using alkaline pre-treated chitosan matrix or alkaline pre-treated chitosan and alkaline pre-treated collagen mixed matrix |
| 03/02/2004 | CA2149441C Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 03/02/2004 | CA2069960C Bispecific heteroantibodies with dual effector functions |
| 02/26/2004 | WO2004017072A1 A cellular assay system for neurofibrillary tangle formation |
| 02/26/2004 | WO2004017051A1 A method of characterizing dendritic cells |
| 02/26/2004 | WO2004016803A2 Method of enhancing cd4+ t cell responses |
| 02/26/2004 | WO2004016795A1 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/26/2004 | WO2004016794A1 Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines |
| 02/26/2004 | WO2004016792A1 Novel expression vector suitable for expression of recombinant protein at low temperature |
| 02/26/2004 | WO2004016790A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 02/26/2004 | WO2004016779A1 A method for transdifferentiating mesenchymal stem cells into neuronal cells |
| 02/26/2004 | WO2004016777A2 Genetically modified non-human mammal cells, procedure for their production and use in toxicity tests |
| 02/26/2004 | WO2004016774A1 Method of amplifying inhibitory nk cell receptor-positive cells |
| 02/26/2004 | WO2004016773A1 Transgenic cloned cow producing human prourokinase and method for producing the same |
| 02/26/2004 | WO2004016772A1 A method of cell re-programming by cytoplasmic transfer |
| 02/26/2004 | WO2004016766A2 Real time measurement of cellular responses |
| 02/26/2004 | WO2004016759A2 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 02/26/2004 | WO2004016758A2 Brain endothelial cell expression patterns |
| 02/26/2004 | WO2004016747A2 Bone marrow cell differentiation |
| 02/26/2004 | WO2004016742A2 α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM |
| 02/26/2004 | WO2004016740A2 Humanized rabbit antibodies |
| 02/26/2004 | WO2004016732A2 Astrocyte modulated genes and uses thereof |
| 02/26/2004 | WO2004016731A2 Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures |
| 02/26/2004 | WO2004016726A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 02/26/2004 | WO2004016639A1 Bmp-2 estrogen responsive element and methods of using the same |
| 02/26/2004 | WO2004016283A2 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 02/26/2004 | WO2004016212A2 Methods and compositions for targeting secretory lysosomes |
| 02/26/2004 | WO2004016151A2 Pthrp-derived modulators of smooth muscle proliferation |
| 02/26/2004 | WO2004004763A3 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 02/26/2004 | WO2004003218A3 Antisense modulation of hypothetical protein loc51249 expression |
| 02/26/2004 | WO2004000369A3 Method of magnetically manipulating a cell with magnetisable particles |
| 02/26/2004 | WO2003106651A3 Spermatogonial cell line |
| 02/26/2004 | WO2003102123A3 Culture systems for the sterile continuous cultivation of cells |
| 02/26/2004 | WO2003100010A3 Cytokine-free growth and maintenance of progenitor cells |
| 02/26/2004 | WO2003096973A3 A direct cellular energy delivery system |
| 02/26/2004 | WO2003089602A3 Toll-like receptor 11 and toll-like receptor 12 |
| 02/26/2004 | WO2003089581A3 A method to increase the rate of cell growth |
| 02/26/2004 | WO2003089578A3 Activation of equine oocytes |
| 02/26/2004 | WO2003087345A3 Stimulation of nerve cell regeneration |
| 02/26/2004 | WO2003087333A3 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 02/26/2004 | WO2003083070A3 Endothelial cells derived from human embryonic stem cells |
| 02/26/2004 | WO2003083066A3 Methods for increasing polypeptide production |
| 02/26/2004 | WO2003083050A3 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 02/26/2004 | WO2003073998A3 Local production and/or delivery of anti-cancer agents by stromal cell precursors |
| 02/26/2004 | WO2003073982A3 Anti-interleukin-1 beta analogs |
| 02/26/2004 | WO2003068911A3 Citrus tristeza virus resistance genes and methods of use |
| 02/26/2004 | WO2003060085A3 Mammalian neural stem cells, compositions and uses thereof |
| 02/26/2004 | WO2003060071A3 Albumin fusion proteins |
| 02/26/2004 | WO2003059953B1 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
| 02/26/2004 | WO2003057829A3 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 02/26/2004 | WO2003057171A3 Activation and expansion of t-cells using an engineered multivalent signaling platform |
| 02/26/2004 | WO2003057014A9 Biomarkers for detecting ovarian cancer |
| 02/26/2004 | WO2003054210B1 Regulated nucleic acid expression system |
| 02/26/2004 | WO2003054019A3 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 02/26/2004 | WO2003047420A3 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 02/26/2004 | WO2003040346A3 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
| 02/26/2004 | WO2003039476A3 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |